CRVL Quote, Financials, Valuation and Earnings

eHealth has a net margin of 10.43% compared to CorVel's net margin of -72.72%. CorVel's return on equity of 32.6% beat eHealth's return on equity of -5.64%.

CorVel has a consensus price target of --, signalling downside risk potential of --. On the other hand eHealth has an analysts' consensus of $7.00 which suggests that it could fall by -25.58%. Given that eHealth has higher upside potential than CorVel, analysts believe eHealth is more attractive than CorVel.

CorVel has a beta of 1.155, which suggesting that the stock is 15.453% more volatile than S&P 500. In comparison eHealth has a beta of 0.311, suggesting its less volatile than the S&P 500 by 68.95%.

CorVel has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. eHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CorVel pays -- of its earnings as a dividend. eHealth pays out -12.52% of its earnings as a dividend.

CorVel quarterly revenues are $224.4M, which are larger than eHealth quarterly revenues of $58.4M. CorVel's net income of $23.4M is higher than eHealth's net income of -$42.5M. Notably, CorVel's price-to-earnings ratio is 69.77x while eHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CorVel is 6.73x versus 0.62x for eHealth. Usually stocks with elevated PS ratios are considered overvalued.

GoHealth has a net margin of 10.43% compared to CorVel's net margin of 5.73%. CorVel's return on equity of 32.6% beat GoHealth's return on equity of -6.99%.

CorVel has a consensus price target of --, signalling downside risk potential of --. On the other hand GoHealth has an analysts' consensus of $19.50 which suggests that it could grow by 33.02%. Given that GoHealth has higher upside potential than CorVel, analysts believe GoHealth is more attractive than CorVel.

CorVel has a beta of 1.155, which suggesting that the stock is 15.453% more volatile than S&P 500. In comparison GoHealth has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

CorVel has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. GoHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CorVel pays -- of its earnings as a dividend. GoHealth pays out -5.64% of its earnings as a dividend.

CorVel quarterly revenues are $224.4M, which are larger than GoHealth quarterly revenues of $118.3M. CorVel's net income of $23.4M is higher than GoHealth's net income of $6.8M. Notably, CorVel's price-to-earnings ratio is 69.77x while GoHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CorVel is 6.73x versus 0.23x for GoHealth. Usually stocks with elevated PS ratios are considered overvalued.

Kingstone Companies has a net margin of 10.43% compared to CorVel's net margin of 17.12%. CorVel's return on equity of 32.6% beat Kingstone Companies's return on equity of 40.22%.

CorVel has a consensus price target of --, signalling downside risk potential of --. On the other hand Kingstone Companies has an analysts' consensus of -- which suggests that it could grow by 15.8%. Given that Kingstone Companies has higher upside potential than CorVel, analysts believe Kingstone Companies is more attractive than CorVel.

CorVel has a beta of 1.155, which suggesting that the stock is 15.453% more volatile than S&P 500. In comparison Kingstone Companies has a beta of 0.738, suggesting its less volatile than the S&P 500 by 26.211%.

CorVel has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kingstone Companies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CorVel pays -- of its earnings as a dividend. Kingstone Companies pays out -- of its earnings as a dividend.

CorVel quarterly revenues are $224.4M, which are larger than Kingstone Companies quarterly revenues of $40.8M. CorVel's net income of $23.4M is higher than Kingstone Companies's net income of $7M. Notably, CorVel's price-to-earnings ratio is 69.77x while Kingstone Companies's PE ratio is 11.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CorVel is 6.73x versus 1.16x for Kingstone Companies. Usually stocks with elevated PS ratios are considered overvalued.

Reliance Global Group has a net margin of 10.43% compared to CorVel's net margin of -24.33%. CorVel's return on equity of 32.6% beat Reliance Global Group's return on equity of -291.14%.

CorVel has a consensus price target of --, signalling downside risk potential of --. On the other hand Reliance Global Group has an analysts' consensus of -- which suggests that it could grow by 4548.44%. Given that Reliance Global Group has higher upside potential than CorVel, analysts believe Reliance Global Group is more attractive than CorVel.

CorVel has a beta of 1.155, which suggesting that the stock is 15.453% more volatile than S&P 500. In comparison Reliance Global Group has a beta of -0.021, suggesting its less volatile than the S&P 500 by 102.104%.

CorVel has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Reliance Global Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. CorVel pays -- of its earnings as a dividend. Reliance Global Group pays out -- of its earnings as a dividend.

CorVel quarterly revenues are $224.4M, which are larger than Reliance Global Group quarterly revenues of $3.4M. CorVel's net income of $23.4M is higher than Reliance Global Group's net income of -$837.3K. Notably, CorVel's price-to-earnings ratio is 69.77x while Reliance Global Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for CorVel is 6.73x versus 0.11x for Reliance Global Group. Usually stocks with elevated PS ratios are considered overvalued.